한글목차

세계의 임상시험 지원 서비스 시장은 2025년 258억 6,000만 달러로 추정되고, 2032년까지 429억 달러에 이를 것으로 예측되고, 2025년부터 2032년까지 연평균 성장률(CAGR) 7.5%를 보일 것으로 예측됩니다.

임상시험 지원 서비스는 신약의 임상시험 중이나 제네릭 의약품이나 바이오시밀러 시장 도입 전 분자분석 중에 제약회사가 이용하는 특징적인 서비스입니다.

시장 역학:

만성증 및 감염증 유행, 창약 및 시장 개척 증가, 임상시험 수 증가, 임상시험 지원 서비스에 대한 수요 증가는 예측 기간 동안 세계 임상시험 지원 서비스 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다. 예를 들어 세계보건기구(WHO)에 따르면 대부분의 WHO 지역에서 국제 임상시험 등록 플랫폼(ICTRP)에 등록된 신규모집 임상시험 수가 꾸준히 증가하고 있습니다. 1999년부터 2022년 사이에 등록된 임상시험의 총수는 미국이 가장 많고(16만8,520건), 이어서 중국(9만4,193건), 일본(6만3,499건) 순이었습니다.

그러나 엄격한 규제 체제와 가난한 의료 인프라가 세계 임상시험 지원 서비스 시장의 성장을 방해할 것으로 예측됩니다.

이 보고서의 주요 특징

• 본 보고서는 세계의 임상시험 지원 서비스 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
• 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
• 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 세계 임상시험 지원 서비스 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• '세계의 임상시험 지원 서비스 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자는 세계의 임상시험 지원 서비스 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 세계에서 임상시험이 증가
  • 엄격한 규제 틀
  • 임상시험 지원 서비스 수요 증가
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시 및 승인
• PEST 분석
• Porter's Five Forces 분석
• 기업 인수합병(M&A) 시나리오

제4장 세계의 임상시험 지원 서비스 시장 - 코로나 바이러스 감염증(COVID-19) 유행의 영향

• COVID-19의 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 임상시험 지원 서비스 시장 : 단계(2020-2032년)

• 제 I 단계
• 제 II 단계
• 제 III 단계
• 제 IV 단계

제6장 세계의 임상시험 지원 서비스 시장 : 서비스별(2020-2032년)

• 임상시험 사이트 관리
• 환자 모집 관리
• 데이터 관리
• 관리 스탭
• 윤리위원회(IRB)
• 기타

제7장 세계의 임상시험 지원 서비스 시장 : 스폰서별(2020-2032년)

• 제약 및 바이오 의약품 기업
• 의료기기 기업
• 기타

제8장 세계의 임상시험 지원 서비스 시장 : 지역별(2020-2032년)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• Wuxi AppTec, Inc.
• IQVIA Holdings, Inc.
• Syneos Health, Inc.
• Eurofins Scientific
• Laboratory Corporation of America Holdings(Labcorp)
• Icon PLC
• ALCURA
• Parexel International Corporation
• PPD, Inc.(Pharmaceutical Product Development)
• Charles River Laboratories International, Inc.

제10장 섹션

• 분석 방법
• 출판사에 대해

영문목차

Clinical Trials Support Services Market is estimated to be valued at USD 25.86 Bn in 2025 and is expected to reach USD 42.9 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Clinical trial support services are distinguishing services used by pharmaceutical companies during the clinical trials of any new drugs or molecular analysis of generics and biosimilars before their introduction in the market. Thus, with the increasing number of clinical trials across the globe, the demand for clinical trials support services is also increasing rapidly.

Market Dynamics:

Increasing prevalence of chronic/infectious disease, increase in drug discovery and development, increasing number of clinical trials, and increasing demand for clinical trials support services are major factors expected to driver growth of the global clinical trials support services market during the forecast period. For instance, According to the World Health Organization (WHO), there was a steady rise in the number of newly recruiting trials registered on the International Clinical Trials Registry Platform (ICTRP) for most WHO regions. The U.S. had a highest total number of trials registered during 1999-2022 (168,520), followed by China (94,193) and Japan (63,499).

However, stringent regulatory framework and poor healthcare infrastructure is expected to hamper the growth of the global clinical trials support services market.

Key features of the study:

• This report provides in-depth analysis of the global clinical trials support services market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global clinical trials support services market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Wuxi AppTec, Inc., Syneos Health, Inc., Eurofins Scientific, Laboratory Corporation of America Holdings (Labcorp), Icon PLC, ALCURA, IQVIA Holdings, Inc., Parexel International Corporation, PPD, Inc. (Pharmaceutical Product Development), and Charles River Laboratories International, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global clinical trials support services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical trials support services market.

Detailed Segmentation:

• Global Clinical Trials Support Services Market, By Phase:
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• Global Clinical Trials Support Services Market, By Service:
  • Clinical Trial Site Management
  • Patient Recruitment Management
  • Data Management
  • Administrative Staff
  • IRB
  • Others
• Global Clinical Trials Support Services Market, By Sponsor:
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others
• Global Clinical Trials Support Services Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Wuxi AppTec, Inc.
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings (Labcorp)
  • Icon PLC
  • ALCURA
  • Parexel International Corporation
  • PPD, Inc. (Pharmaceutical Product Development)
  • Charles River Laboratories International, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Phase
  • Market Snapshot, By Service
  • Market Snapshot, By Sponsor
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing number of clinical trials across the globe
  • Stringent regulatory framework
  • Increasing demand for clinical trials support services
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Clinical Trials Support Services Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Clinical Trials Support Services Market, By Phase, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Phase I
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Phase II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Phase III
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Phase IV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Clinical Trials Support Services Market, By Service, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Trial Site Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Patient Recruitment Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Data Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Administrative Staff
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• IRB
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Clinical Trials Support Services Market, By Sponsor, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical & Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Medical Device Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Clinical Trials Support Services Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Phase, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sponsor, 2020-2032,(US$ Bn)

9. Competitive Landscape

• Wuxi AppTec, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IQVIA Holdings, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Syneos Health, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratory Corporation of America Holdings (Labcorp)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Icon PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ALCURA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Parexel International Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PPD, Inc. (Pharmaceutical Product Development)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Charles River Laboratories International, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us